Nirsevimab: a change of paradigm in the prophylaxis of Respiratory Syncytial Virus disease among infants.

Saved in:
Bibliographic Details
Title: Nirsevimab: a change of paradigm in the prophylaxis of Respiratory Syncytial Virus disease among infants.
Authors: Rezza G; Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Cereda D; General Directorate, Regional Welfare Service, Lombardy Region, Milan, Italy., Rizzo C; National Immunization Technical Advisory Group (NITAG), Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy., Cuciniello R; Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., D'Amelio AC; Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Villani A; National Immunization Technical Advisory Group (NITAG), Italy.; Bambino Gesù Children's Hospital IRCCS, Hospital University Pediatrics Clinical Area, Rome, Italy.; Department of Systems Medicine, University of Rome Tor Vergata, Italy., Signorelli C; Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.; National Immunization Technical Advisory Group (NITAG), Italy.
Source: Annali di igiene : medicina preventiva e di comunita [Ann Ig] 2025 Sep-Oct; Vol. 37 (5), pp. 684-688. Date of Electronic Publication: 2025 Jun 12.
Publication Type: Letter
Journal Info: Publisher: Societa Editrice Universo Country of Publication: Italy NLM ID: 9002865 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 3035-5559 (Electronic) Linking ISSN: 11209135 NLM ISO Abbreviation: Ann Ig Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:3035-5559
DOI:10.7416/ai.2025.2712